Velsipity

Medicinal product

(Invented) name

Velsipity

Active substance (s)

Etrasimodas

Strength

2 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AE05, etrasimod

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2024-02-16

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Etrasimodas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112914	99032	1099032	lizdinė plokštelė	N28		Receptinis	EU/1/23/1790/001	Netiekiama	-	-	No	-	-
112915	99033	1099033	lizdinė plokštelė	N98		Receptinis	EU/1/23/1790/002	Netiekiama	-	-	No	-	-
112916	99034	1099034	buteliukas	N30		Receptinis	EU/1/23/1790/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-02-16	Registruotas